Lazard Asset Management
ORGO icon

Lazard Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Lazard Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,005
Closed -$187K – 2031
2025
Q4 		$187K Buy
+36,005
New +$174K ﹤0.01% 1664
2025
Q2 		– Sell
-649,384
Closed -$2.81M – 2468
2025
Q1 		$2.81M Buy
649,384
+477,690
+278% +$1.93M ﹤0.01% 863
2024
Q4 		$549K Buy
171,694
+94,514
+122% +$317K ﹤0.01% 1336
2024
Q3 		$220K Buy
77,180
+26,361
+52% +$73.9K ﹤0.01% 1586
2024
Q2 		$142K Buy
50,819
+28,028
+123% +$75.2K ﹤0.01% 1654
2024
Q1 		$64K Sell
22,791
-1,689
-7% -$5.74K ﹤0.01% 1670
2023
Q4 		$100K Buy
24,480
+1,561
+7% +$4.37K ﹤0.01% 1655
2023
Q3 		$72K Hold
22,919
– – ﹤0.01% 1749
2023
Q2 		$76K Hold
22,919
– – ﹤0.01% 1684
2023
Q1 		$48K Buy
22,919
+9,520
+71% +$23.5K ﹤0.01% 1816
2022
Q4 		$36K Sell
13,399
-14,695
-52% -$42.9K ﹤0.01% 1947
2022
Q3 		$91K Buy
28,094
+13,166
+88% +$59.5K ﹤0.01% 1506
2022
Q2 		$72K Buy
14,928
+5,822
+64% +$35.8K ﹤0.01% 1649
2022
Q1 		$69K Buy
9,106
+8,873
+3,808% +$68.7K ﹤0.01% 1573
2021
Q4 		$2K Sell
233
-919
-80% -$9.76K ﹤0.01% 2223
2021
Q3 		$16K Sell
1,152
-6,505
-85% -$101K ﹤0.01% 2044
2021
Q2 		$127K Sell
7,657
-2,183
-22% -$40.7K ﹤0.01% 1291
2021
Q1 		$179K Hold
9,840
– – ﹤0.01% 1116
2020
Q4 		$74K Buy
9,840
+8,688
+754% +$41.3K ﹤0.01% 1266
2020
Q3 		$4K Buy
+1,152
New +$4.55K ﹤0.01% 1553

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Lazard Asset Management's ORGO Position: Q1 2026 in Review

Lazard Asset Management sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 36,005 shares — an estimated $187K sold.

Lazard Asset Management first reported a position in ORGO in Q3 2020 and held it in 20 quarters. The position peaked at $2.81M in Q1 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Lazard Asset Management reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
  • Lazard Asset Management sold 36,005 Organogenesis Holdings shares in Q1 2026, an estimated $187K.
  • Lazard Asset Management first reported a position in Organogenesis Holdings in Q3 2020 and held it in 20 quarters.
  • Lazard Asset Management's Organogenesis Holdings position peaked at $2.81M in Q1 2025.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.